International Journal of Commerce and Management Research

Merger and acquisition in global pharmaceutical sector is not a new concept. The burst in M&A tendency in pharmaceutical sector is an inception to make the industry look like a pyramid. The present study is based on recent merger of Sun Pharmaceutical Industries and Ranbaxy; Sun Pharmaceutical Industries is a multinational pharmaceutical company having strong presence in the generic drug market in India. The company has a tremendous track record of 20 successful acquisitions. Sun Pharma after acquisition of Ranbaxy became India’s 1st and world’s 5th largest generic drug making company. Our study deals with impact of acquisition on financial health and profitability of the company. To come to a conclusion pre-acquisition and post-acquisition financial data have been analysed.